Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis

Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis

The presence of a pro-oxidant state in patients with schizophrenia may account for the increased risk of atherosclerosis and cardiovascular disease in this group and supports the potential utility of circulating biomarkers of oxidative stress for risk stratification and management. We investigated t...

Bibliografiset tiedot
Päätekijät:	Angelo Zinellu, Stefania Sedda, Arduino A. Mangoni
Aineistotyyppi:	Artikkeli
Kieli:	English
Julkaistu:	MDPI AG 2023-07-01
Sarja:	Antioxidants
Aiheet:	schizophrenia paraoxonase-1 paraoxonase arylesterase oxidative stress HDL cholesterol
Linkit:	https://www.mdpi.com/2076-3921/12/8/1484

Samankaltaisia teoksia

Serum arylesterase and paraoxonase activities in patients with ovarian tumors
Tekijä: Slawomir Michalak, et al.
Julkaistu: (2014-12-01)

Association between Paraoxonase/Arylesterase Activity of Serum PON-1 Enzyme and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Tekijä: Gian Luca Erre, et al.
Julkaistu: (2022-11-01)

Evaluation of paraoxonase, arylesterase, and homocysteine thiolactonase activities in patients with diabetes and incipient diabetes nephropathy
Tekijä: Ayan Durmu§, et al.
Julkaistu: (2019-01-01)

Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients
Tekijä: Fazile Hatipoglu Erdem, et al.
Julkaistu: (2010-01-01)

Assessment of serum paraoxonase and arylesterase activities in early pregnancy failure
Tekijä: H Toy, et al.
Julkaistu: (2009-02-01)

Total oxidant status, total antioxidant status, and paraoxonase and arylesterase activities during laparoscopic cholecystectomy
Tekijä: Hande Koksal, et al.
Julkaistu: (2010-01-01)

Serum Lipid Profiles, Relationship Between Paraoxonase/Arylesterase Activity and High-density Lipoprotein Levels in Patients with Migraine
Tekijä: Yasemin Eren, et al.
Julkaistu: (2017-09-01)

Paraoxonase 1 Phenotype and Paraoxonase Activity in Asthmatic Patients
Tekijä: Nurhan Sarioglu, et al.
Julkaistu: (2015-02-01)

Arylesterase activity of paraoxonase 1 and intensity of oxidative processes in the blood of dialysis patients
Tekijä: L. Korol, et al.
Julkaistu: (2019-12-01)

Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer’s Disease and Vascular Dementia
Tekijä: Arianna Romani, et al.
Julkaistu: (2020-05-01)

Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock—A Prospective Pilot Study
Tekijä: Alexander C. Reisinger, et al.
Julkaistu: (2020-10-01)

Association between inflammatory markers and serum paraoxonase and arylesterase activities in the general population: a cross-sectional study
Tekijä: Christa Meisinger, et al.
Julkaistu: (2021-07-01)

The phenotype distribution of paraoxonase-1 in patients with multiple myeloma, bladder, and colorectal cancer
Tekijä: Ellidag Hamit Yasar, et al.
Julkaistu: (2014-01-01)

Effects of PON1 QR192 genetic polymorphism and paraoxonase, arylesterase activities on deep vein thrombosis
Tekijä: Akbalik Hasim, et al.
Julkaistu: (2023-05-01)

Relationship of Serum Paraoxonase Enzyme Activity and Thermal Burn Injury
Tekijä: Serap Yildirim, et al.
Julkaistu: (2012-12-01)

Lipid associated antioxidants: arylesterase and paraoxonase-1 in benign prostatic hyperplasia treatment-naïve patients
Tekijä: George Awuku Asare, et al.
Julkaistu: (2018-03-01)

Comparison of Total Oxidative Stress, Total Antioxidant Capacity, and Paraoxonase, Arylesterase, and Lipid Peroxidase Levels in Aqueous Humor and Serum of Diabetic and Non-Diabetic Patients with Catarac
Tekijä: Cengiz Caner, et al.
Julkaistu: (2012-01-01)

Arylesterase activity of Paraoxonase 1 - prognostic factor for one-year survival in patients with acute myocardial infarction
Tekijä: Ciumărnean Lorena, et al.
Julkaistu: (2018-07-01)

Paraoxonase 1 and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis
Tekijä: Kazuhiko Kotani, et al.
Julkaistu: (2021-04-01)

Evaluation of Serum malondialdehyde concentrations and enzymatic activity of paraoxonase and arile esterase in women with a recurrent spontaneous abortion
Tekijä: Sanjadi M, et al.
Julkaistu: (2019-12-01)

The contribution of paraoxonase 1 and myeloperoxidase to HDL-cholesterol functionality
Tekijä: Malara Marzena, et al.
Julkaistu: (2016-05-01)

The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3
Tekijä: Ajda Taler-Verčič, et al.
Julkaistu: (2020-12-01)

Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene
Tekijä: Muhammad Idrees, et al.
Julkaistu: (2018-07-01)

The relationship between serum ferritin levels and serum lipids and HDL function with respect to age and gender
Tekijä: Hamit Yasar Ellidag, et al.
Julkaistu: (2016-12-01)

Paraoxonase 1 gene polymorphisms in lipid oxidation and atherosclerosis development
Tekijä: Marija Vavlukis, et al.
Julkaistu: (2022-09-01)

Paraoxonase 1 as an important antiatherogenic agent
Tekijä: Ewa Lidia Krzewicka-Romaniuk, et al.
Julkaistu: (2019-01-01)

Paraoxonase 1 as an important antiatherogenic agent
Tekijä: Ewa Lidia Krzewicka-Romaniuk, et al.
Julkaistu: (2019-01-01)

Paraoxonase 1 and Chronic Obstructive Pulmonary Disease: A Meta-Analysis
Tekijä: Jun Watanabe, et al.
Julkaistu: (2021-11-01)

Ghrelin, nitrite and paraoxonase/arylesterase concentrations in cement plant workers
Tekijä: Aydin Suleyman, et al.
Julkaistu: (2010-01-01)

Paraoxonase Activities in Metabolic Syndrome in Children and Adolescents
Tekijä: Arati Adhe-Rojekar, et al.
Julkaistu: (2018-01-01)

Baculovirus-mediated expression and purification of human serum paraoxonase 1A
Tekijä: Robert J. Brushia, et al.
Julkaistu: (2001-06-01)

Effects of Vitamin C on Paraoxonase1 Arylesterase Activity in Rats Exposed to Arsenic
Tekijä: Felor Zargari*, et al.
Julkaistu: (2017-03-01)

Phytochemicals as Modulators of Paraoxonase-1 in Health and Diseases
Tekijä: Zahra Najafi Arab, et al.
Julkaistu: (2022-06-01)

Usefulness of the Measurement of Serum Paraoxonase-1 Arylesterase Activity in the Diagnoses of COVID-19
Tekijä: Xavier Gabaldó, et al.
Julkaistu: (2022-06-01)

Paraoxonase-1 Concentrations in Obstructive Sleep Apnoea: A Systematic Review and Meta-Analysis
Tekijä: Maria Carmina Pau, et al.
Julkaistu: (2022-04-01)

Paraoxonase-1 Phenotype and Its Relationship with Mean Platelet Volume and Oxidative Stress in Coronary Artery Disease
Tekijä: Şahabettin SELEK, et al.
Julkaistu: (2015-08-01)

Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q→R genetic polymorphism
Tekijä: Huibi Cao, et al.
Julkaistu: (1999-01-01)

Distribution of Paraoxonase 1 polymorphisms and activities in obese patients
Tekijä: Ciumărnean Lorena, et al.
Julkaistu: (2013-12-01)

Preferential inhibition of paraoxonase activity of human paraoxonase 1 by negatively charged lipids
Tekijä: Su Duy Nguyen, et al.
Julkaistu: (2004-12-01)

The effect of 16 weeks of aerobic training on activity of serum paraoxonase, arylesterase, and lipid profile in postmenopausal women
Tekijä: R ghasemi, et al.
Julkaistu: (2017-10-01)